CLINICAL_TRIALS
trial_result
· 2021-09-22
Clinical Trial Update: Study of Tesevatinib Monotherapy in Patients With Recurrent Glioblastoma [Phase 2]
Summary
Phase 2 trial of tesevatinib monotherapy in recurrent glioblastoma has completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Kadmon Corporation, LLC | Conditions: Glioblastoma, Recurrent Glioblastoma | Phase 2 | Status: COMPLETED | Results posted: 2021-09-22